These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Viral genome quantification as a tool for improving patient management: the example of HIV, HBV, HCV and CMV. Berger A; Preiser W J Antimicrob Chemother; 2002 May; 49(5):713-21. PubMed ID: 12003963 [TBL] [Abstract][Full Text] [Related]
5. Management of HCV peri-transplant recapitulates management of CMV. Griffiths P; Haque T; Marshall A Rev Med Virol; 2019 Nov; 29(6):e2091. PubMed ID: 31709643 [No Abstract] [Full Text] [Related]
6. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation. Hebart H; Müller C; Löffler J; Jahn G; Einsele H Bone Marrow Transplant; 1996 May; 17(5):861-8. PubMed ID: 8733710 [TBL] [Abstract][Full Text] [Related]
7. [Quick diagnosis of cytomegalovirus infection]. Lautenschlager I Duodecim; 1990; 106(13):979-83. PubMed ID: 1670342 [No Abstract] [Full Text] [Related]
8. [The hepatitis C virus: after the track of the human immunodeficiency virus]. Pérez-Olmeda M; Rodríguez-Rosado R; García-Samaniego J; Soriano V Rev Clin Esp; 1999 Jan; 199(1):5-7. PubMed ID: 10089769 [No Abstract] [Full Text] [Related]
9. Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact. Baldanti F; Gerna G J Antimicrob Chemother; 2003 Sep; 52(3):324-30. PubMed ID: 12888590 [TBL] [Abstract][Full Text] [Related]
10. Editorial commentary: Management of hepatitis C Virus in HIV-infected patients in the era of direct-acting antivirals. Zeremski M; Martinez AD; Talal AH Clin Infect Dis; 2014 Mar; 58(6):880-2. PubMed ID: 24336913 [No Abstract] [Full Text] [Related]
11. Antiviral therapies in children: has their time arrived? Kimberlin DW Pediatr Clin North Am; 2005 Jun; 52(3):837-67, vii. PubMed ID: 15925665 [TBL] [Abstract][Full Text] [Related]
12. Significance of qualitative polymerase chain reaction combined with quantitation of viral load in the diagnosis and follow-up of cytomegalovirus infection after solid-organ transplantation. Vanpoucke H; Van Vlem B; Vanholder R; Van Renterghem L Intervirology; 1999; 42(5-6):398-404. PubMed ID: 10702723 [TBL] [Abstract][Full Text] [Related]
13. The distinct contributions of fitness and genetic barrier to the development of antiviral drug resistance. Götte M Curr Opin Virol; 2012 Oct; 2(5):644-50. PubMed ID: 22964133 [TBL] [Abstract][Full Text] [Related]
14. HIV and hepatitis C co-infection. Jones R; Dunning J; Nelson M Int J Clin Pract; 2005 Sep; 59(9):1082-7. PubMed ID: 16115185 [TBL] [Abstract][Full Text] [Related]
18. [A review on new commercial methods for HIV-1 and HCV viral load determinations]. Aguilera A; Alba JM; Lamas LM; Suárez ML; Galán JC Enferm Infecc Microbiol Clin; 2010 Jan; 28 Suppl 1():62-7. PubMed ID: 20172426 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B and C virus resistance to antiviral therapies--EASL-AASLD-APASL-ALEH-IASL conference. Buti M IDrugs; 2008 Apr; 11(4):239-41. PubMed ID: 18379952 [No Abstract] [Full Text] [Related]